Maximum information designs

Clinical Trials

Volumn 2, Issue 5, 2005, Pages 453-464

  Lachin, John M ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DATA ANALYSIS; HAZARD; HUMAN; INFORMATION SCIENCE; POPULATION RESEARCH; PRIORITY JOURNAL; PROBABILITY; REVIEW; STATISTICAL ANALYSIS; VARIANCE;

CLINICAL TRIALS; DATA INTERPRETATION, STATISTICAL; HUMANS; RESEARCH DESIGN; SAMPLE SIZE;

EID: 27744591898     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1191/1740774505cn115oa     Document Type: Review

References (33)

1. Lachin JM. Introduction to sample size determination and power analysis for clinical trials. Control Clin Trials 1981; 2: 93-113.
2. Donner A. Approaches to sample size estimation in the design of clinical trials-A review. Stat Med 1984; 3: 199-214.
3. Machin D, Campbell MJ. Stat Tables Design Clin Trials. Oxford: Blackwell Scientific Publications, 1987.
4. Chow S-C, Shao J, Wang H. Sample size calculations in clinical research. New York: Marcel Dekker, 2003.
5. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983; 70: 659-63.
6. Lan KKG, Zucker DM. Sequential monitoring of clinical trials: The role of information and Brownian motion. Stat Med 1993; 12: 753-65.
7. Lan KKG, Reboussin DM, DeMets DL. Information and information fractions for design and sequential monitoring of clinical trials. Commun Stat - Theory and Methods 1994; 23: 403-20.
8. Wittes J. On changing a long-term clinical trial midstream. Stat Med 2002; 27: 2789-95.
9. Lachin JM. Sample size determinations for r × c comparative trials. Biometrics 1977; 33: 315-24.
10. Lachin JM. Power and sample size evaluation for the McNemar test with application to matched case-control studies. Stat Med 1992; 11: 1239-51.
11. Cox DR. Regression models and life-tables (with discussion). J Roy Statist Soc, B, 1992; 34: 187-220.
12. Harrington DP, Fleming TR. A class of rank test procedures for censored survival data. Biometrika 1982; 69: 553-66.
13. Lakatos E. Sample sizes based on the log-rank statistic in complex clinical trials. Biometrics 1988; 44: 229-41.
14. George SL, Desu MM. Planning the size and duration of a clinical trial studying the time to some critical event. J Chronic Dis 1974; 27: 15-29.
15. Schoenfeld D. The asymptotic properties of nonparametric tests for comparing survival distributions. Biometrika 1981; 68: 316-19.
16. Schoenfeld D. Sample-size formula for the proportional-hazards regression model. Biometrics 1983; 39: 499-503.
17. Rubenstein LV, Gail MH, Santner TJ. Planning the duration of a comparative clinical trial with losses to follow-up and a period of continued observation. J Chronic Dis 1981; 34: 469-79.
18. Lachin JM, Foulkes MA. Evaluation of sample size and power for analyses of survival with allowance for non-uniform patient entry, losses to follow-up, non-compliance and stratification. Biometrics 1986; 42: 507-19.
19. Tsiatis AA. Repeated significance testing for a general class of statistics used in censored survival analysis. J Am Statist Assoc 1982; 77: 855-61.
20. Lan KKG, DeMets DL. Group sequential procedures: Calendar versus information time. Stat Med 1989; 8: 1191-98.
21. Lan KKG, Lachin JM. Group sequential logrank tests in a maximum duration trial. Biometrics 1990; 46: 759-70.
22. Kim KM, Boucher H, Tsiatis AA. Design and analysis of group sequential logrank tests in maximum information versus duration trials. Biometrics 51: 988-1000.
23. Makuch RW, Simon RM. Sample size requirements for comparing time-to-failure among k treatment groups. J Chronic Dis 1982; 35: 861-67.
24. Holm S. A Simple sequentially rejective multiple test procedure. Scand J Statist 1979; 6: 65-70.
25. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988; 75: 800-802.
26. Dunnett CW. A multiple comparison procedure for comparing several treatments with a control. J Am Statist Assoc 1955; 50: 1096-121.
27. Scharfstein DO, Tsiatis AA, Robins JM. Semiparametric efficiency and its implication on the design and analysis of group sequential studies. J Am Statist Assoc 1997; 92: 1342-50.
28. Mehta CR, Tsiatis AA. Flexible sample size considerations using information-based interim monitoring. Drug Inf J 2001; 35: 1095-2001.
29. Jennison C, Turnbull BW. Group sequential methods with applications to clinical trials. New York: Chapman and Hall/CRC, 2000.
30. Hollander M, Wolfe DA. Nonparametric statistical methods. New York, NY: John Wiley and Sons, 1973.
31. Wei LJ, Lachin JM. Two-sample asymptotically distribution-free tests for incomplete multivariate observations. J Am Statist Assoc 1984; 79: 653-61.
32. Su JQ, Lachin JM. Group sequential distribution-free methods for the analysis of multivariate observations. Biometrics 1992; 48: 1033-42.
33. Rochon J. Application of GEE procedures for sample size calculations in repeated measures experiments. Stat Med 1998; 17: 1643-58.